Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Shares Issued (2018 - 2025)

Organogenesis Holdings has reported Shares Issued over the past 7 years, most recently at $2000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $2000.0 for Q4 2025, down 99.81% from a year ago — trailing twelve months through Dec 2025 was $157000.0 (down 87.41% YoY), and the annual figure for FY2025 was $157000.0, down 87.41%.
  • Shares Issued for Q4 2025 was $2000.0 at Organogenesis Holdings, down from $130000.0 in the prior quarter.
  • Over the last five years, Shares Issued for ORGO hit a ceiling of $1.8 million in Q2 2022 and a floor of $2000.0 in Q4 2025.
  • Median Shares Issued over the past 4 years was $180000.0 (2024), compared with a mean of $436307.7.
  • Peak annual rise in Shares Issued hit 3150.0% in 2025, while the deepest fall reached 99.81% in 2025.
  • Organogenesis Holdings' Shares Issued stood at $83000.0 in 2021, then crashed by 66.27% to $28000.0 in 2022, then skyrocketed by 3696.43% to $1.1 million in 2024, then crashed by 99.81% to $2000.0 in 2025.
  • The last three reported values for Shares Issued were $2000.0 (Q4 2025), $130000.0 (Q3 2025), and $25000.0 (Q1 2025) per Business Quant data.